DHR
★★☆☆☆ PasstemplateDanaher Corporation
Healthcare · sector percentile 86
Session move
$218.49
Vol 0.89× avg
60/100 quant · tgt $239.05
RS60 +5.8% vs SPY · ADV$ 967.7M
session 2026-10-07 · Snapshot — not live tape
Since last scan
2026-10-07 → 2026-10-08
Context only — not a buy/sell signal. Built from scan history and cached news/filings.
Snapshot quote
session 2026-10-07 · scan 2026-10-08 · pushed 10-08 11:56 ET · Regular session (stale)
Show quote fundamentalsHide quote fundamentals
- Last (scan/close)
- $218.49
- Previous close
- $215.61
- Pushed last
- $213.74 (stale) · 10-08 11:56 ET · Regular session
- Session open
- $217.77
- Last session range
- $214.40 – $220.39
- 52-week range
- $160.60 – $241.78
- Session volume
- 3,974,063
- Avg volume (20d)
- 4,484,633
- Market cap
- $153.60B
- PE (TTM)
- 38.95
- Forward PE
- 23.50
- Dividend yield
- 0.67%
- 1y target est.
- $239.05
- Next earnings
- 2026-10-20
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes.
If you put $1,000.00 in
1y ago
$1,071.98
+7%
5y ago
$841.89
−16%
Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.
Market briefing
Curated digest — not a trade signal. Headlines and links as provided by the producer.
- Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?
When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioprocessing unit missed expectations, signaling continued softness in broader biopharma demand. The news hit European supplier Sartorius AG, which traded lower […]
Yahoo · 2026-08-14
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — DHR scores 59.5/100 (Pass) with revenue growth at 5.5% and a multi-factor profile supporting the current ranking.
- Risks — Key risks for DHR include valuation compression, sector rotation, and any deterioration in earnings momentum or balance-sheet leverage. Context: cached next earnings 2026-10-20.
- Target Upside — Consensus implied upside is 9.4%. Category 'Pass' suggests monitoring position sizing against the 100-point model thresholds.
Score History
30 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-10-08$218.49+$2.8859.5Pass
- 2026-10-07$215.61−$5.6060.7Pass
- 2026-10-06$221.21+$7.1559.9Pass
- 2026-10-05$214.06+$2.3059.5Pass
- 2026-10-02$211.76−$9.7957.9Pass
- 2026-10-01$221.55−$4.5659.2Pass
- 2026-09-30$226.11−$1.2259.9Pass
- 2026-09-29$227.33+$2.8459.4Pass
- 2026-09-28$224.49+$0.7258.4Pass
- 2026-09-25$223.77+$2.2160.2Pass
- 2026-09-24$221.56+$0.4761.1Pass
- 2026-09-23$221.09+$5.2561.6Pass
- 2026-09-22$215.84+$4.0362.5Pass
- 2026-09-21$211.81−$0.6963.3Pass
- 2026-09-18$212.50+$4.1463.1Pass
- 2026-09-17$208.36−$1.0062.3Pass
- 2026-09-16$209.36+$6.1161.9Pass
- 2026-09-15$203.25+$3.1162.7Pass
- 2026-09-14$200.14−$0.3962.4Pass
- 2026-09-11$200.53−$4.3261.6Pass
- 2026-09-10$204.85−$0.3861.5Pass
- 2026-09-09$205.23−$2.4362.7Pass
- 2026-09-08$207.66$0.0063.5Pass
- 2026-09-07$207.66−$3.3763.5Pass
- 2026-09-04$211.03+$1.1263.1Pass
- 2026-09-03$209.91+$2.9865.5Pass
- 2026-09-02$206.93−$6.6364.9Pass
- 2026-09-01$213.56−$2.5164.6Pass
- 2026-08-31$216.07+$0.3964.0Pass
- 2026-08-28$215.68—63.8Pass
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 47.8%
- vs 20d (z)
- 0.56
- Short vol
- 724,993
- Status
- ok
Squeeze pressure score
full35/100
- Short leg
- 28
- Call leg
- 55
- Activity
- 1.7
- Call vol share
- 59.0%
- PCR (vol)
- 0.69
- Call OI share
- 64.5%
- ATM IV
- 0.0%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
Disclosure score
Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.
No recent SEC filings or earnings calendar inputs in the score window yet.
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
Earnings surprise (quant context)
From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.
Last reported surprise +0.6%
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-10-20yahoo_calendar
- Last earnings
- —
- SEC ↗42026-08-24
FORM 4
- SEC ↗42026-08-06
FORM 4
- SEC ↗42026-08-06
FORM 4
- SEC ↗42026-08-06
FORM 4
- SEC ↗42026-08-06
FORM 4
- SEC ↗42026-08-06
FORM 4
- SEC ↗42026-08-06
FORM 4
- SEC ↗42026-08-06
FORM 4
- SEC ↗42026-08-06
4
- SEC ↗42026-08-06
4
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.